HIGHLIGHTS
- who: Wen Ouyang from the Hospital of Wuhan UniversityOur inclusion criteria are: (1) NSCLC was confirmed by cytology (, pts), or histology (, pts) (World Health Organization, WHO) have published the research work: Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer, in the Journal: (JOURNAL)
- what: In the study , compared with patients without BM, patients developing metachronous BM during the course of first-generation EGFR-TKIs treatment were at a higher risk on OS (HR=1.86, 95%CI:1.07-3.26) (Fig 3), which was on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.